This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Hummingbird Diagnostics Gmbh. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Andre Franke - Innovator in Diagnostic Methods for Inflammatory Bowel Disease
Introduction
Andre Franke is a notable inventor based in Kronshagen, Germany. He has made significant contributions to the field of medical diagnostics, particularly in relation to inflammatory bowel disease (IBD). His innovative approach focuses on the use of microRNAs (miRNAs) as non-invasive biomarkers for diagnosing IBD.
Latest Patents
One of Andre Franke's key patents is titled "MiRNAs as non-invasive biomarkers for inflammatory bowel disease." This invention relates to a method for diagnosing IBD by determining expression profiles of miRNAs that are representative for the diagnosis of IBD compared to a reference. Additionally, the patent includes a kit for diagnosing IBD, which comprises means for determining these expression profiles of miRNAs.
Career Highlights
Andre Franke is associated with Hummingbird Diagnostics GmbH, where he applies his expertise in developing diagnostic tools. His work has the potential to improve the accuracy and efficiency of IBD diagnosis, benefiting both patients and healthcare providers.
Collaborations
Some of Andre Franke's coworkers include Matthias Hubenthal and Georg Hemmrich-Stanisak. Their collaborative efforts contribute to advancing research and innovation in the field of diagnostics.
Conclusion
Andre Franke's contributions to the field of medical diagnostics, particularly through his patent on miRNAs as biomarkers for IBD, highlight his role as an innovator. His work at Hummingbird Diagnostics GmbH exemplifies the impact of research and collaboration in advancing healthcare solutions.